Sheng F, Li M, Yu J, Yang S, Zou L, Yang G
Front Immunol. 2025; 16:1533335.
PMID: 39925809
PMC: 11802536.
DOI: 10.3389/fimmu.2025.1533335.
Hayashi R, Srisomboon Y, Iijima K, Maniak P, Tei R, Kobayashi T
J Allergy Clin Immunol. 2023; 153(3):793-808.e2.
PMID: 38000698
PMC: 10939907.
DOI: 10.1016/j.jaci.2023.10.031.
Loinjak D, Mihic D, Smolic R, Maricic L, Sahinovic I, Smolic M
Biomedicines. 2023; 11(7).
PMID: 37509486
PMC: 10376760.
DOI: 10.3390/biomedicines11071847.
McDaniel M, Lara H, von Moltke J
Mucosal Immunol. 2023; 16(1):86-97.
PMID: 36642383
PMC: 10290812.
DOI: 10.1016/j.mucimm.2022.11.002.
Gao Y, Cai L, Li L, Zhang Y, Li J, Luo C
Int J Mol Sci. 2022; 23(21).
PMID: 36362440
PMC: 9658128.
DOI: 10.3390/ijms232113656.
Mouse Strain-Dependent Difference Toward the Allergen Serine Protease-Like Protein D Reveals a Novel Regulator of IL-33.
Teufelberger A, Van Nevel S, Hulpiau P, Nordengrun M, Savvides S, De Graeve S
Front Immunol. 2020; 11:582044.
PMID: 33072128
PMC: 7544847.
DOI: 10.3389/fimmu.2020.582044.
IL-33/ST2 Axis in Organ Fibrosis.
Kotsiou O, Gourgoulianis K, Zarogiannis S
Front Immunol. 2018; 9:2432.
PMID: 30405626
PMC: 6207585.
DOI: 10.3389/fimmu.2018.02432.
Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
Hong J, Kim S, Lin P
J Interferon Cytokine Res. 2018; 39(1):61-71.
PMID: 30256696
PMC: 6350413.
DOI: 10.1089/jir.2018.0044.
Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage.
Scott I, Majithiya J, Sanden C, Thornton P, Sanders P, Moore T
Sci Rep. 2018; 8(1):3363.
PMID: 29463838
PMC: 5820248.
DOI: 10.1038/s41598-018-21589-2.
Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment.
Davis B, Stucke E, Khorki M, Litosh V, Rymer J, Rochman M
JCI Insight. 2016; 1(4):e86355.
PMID: 27158675
PMC: 4855700.
DOI: 10.1172/jci.insight.86355.
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung.
Borthwick L
Semin Immunopathol. 2016; 38(4):517-34.
PMID: 27001429
PMC: 4896974.
DOI: 10.1007/s00281-016-0559-z.
Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses.
Hristova M, Habibovic A, Veith C, Janssen-Heininger Y, Dixon A, Geiszt M
J Allergy Clin Immunol. 2015; 137(5):1545-1556.e11.
PMID: 26597162
PMC: 4860024.
DOI: 10.1016/j.jaci.2015.10.003.
AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites.
Kim L, Morita R, Kobayashi Y, Eisenbarth S, Lee C, Elias J
Proc Natl Acad Sci U S A. 2015; 112(22):E2891-9.
PMID: 26038565
PMC: 4460510.
DOI: 10.1073/pnas.1507393112.
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.
Oczypok E, Milutinovic P, Alcorn J, Khare A, Crum L, Manni M
J Allergy Clin Immunol. 2015; 136(3):747-756.e4.
PMID: 25930197
PMC: 4562894.
DOI: 10.1016/j.jaci.2015.03.011.
Eosinophils in mucosal immune responses.
Travers J, Rothenberg M
Mucosal Immunol. 2015; 8(3):464-75.
PMID: 25807184
PMC: 4476057.
DOI: 10.1038/mi.2015.2.
Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease.
Kottyan L, Davis B, Sherrill J, Liu K, Rochman M, Kaufman K
Nat Genet. 2014; 46(8):895-900.
PMID: 25017104
PMC: 4121957.
DOI: 10.1038/ng.3033.
Interleukin 33: a switch-hitting cytokine.
Villarreal D, Weiner D
Curr Opin Immunol. 2014; 28:102-6.
PMID: 24762410
PMC: 4118594.
DOI: 10.1016/j.coi.2014.03.004.
Interleukin-33 in the human placenta.
Topping V, Romero R, Than N, Tarca A, Xu Z, Kim S
J Matern Fetal Neonatal Med. 2012; 26(4):327-38.
PMID: 23039129
PMC: 3563729.
DOI: 10.3109/14767058.2012.735724.
Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion.
Luzina I, Pickering E, Kopach P, Kang P, Lockatell V, Todd N
J Immunol. 2012; 189(1):403-10.
PMID: 22634619
PMC: 3381874.
DOI: 10.4049/jimmunol.1200259.
Mast Cells Respond to Cell Injury through the Recognition of IL-33.
Lunderius-Andersson C, Enoksson M, Nilsson G
Front Immunol. 2012; 3:82.
PMID: 22566963
PMC: 3342375.
DOI: 10.3389/fimmu.2012.00082.